XML 68 R53.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions (Narrative) (Details)
$ / shares in Units, € in Millions, SFr in Millions, $ in Millions
1 Months Ended 12 Months Ended
Dec. 31, 2015
CHF (SFr)
Dec. 08, 2015
USD ($)
Sep. 15, 2015
USD ($)
Aug. 31, 2015
USD ($)
$ / shares
Jul. 08, 2015
USD ($)
Jul. 08, 2015
EUR (€)
Dec. 31, 2014
USD ($)
Dec. 31, 2014
CHF (SFr)
Dec. 31, 2014
USD ($)
Dec. 31, 2015
USD ($)
Reporting_Unit
Business
Jul. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Business
Dec. 31, 2013
USD ($)
Business
Dec. 31, 2013
EUR (€)
Business
Business Acquisition [Line Items]                            
Assumed debt             $ 138.5   $ 138.5 $ 417.0   $ 138.5 $ 21.2  
Goodwill                   9,862.2   1,643.6 517.5  
Net cash consideration                   $ 14,305.0   3,128.4 882.5  
Number of segments | Reporting_Unit                   5        
Pall Corporation                            
Business Acquisition [Line Items]                            
Business acquisition, share price | $ / shares       $ 127.20                    
Business combination, consideration transferred       $ 13,600.0                    
Assumed debt       417.0           $ 416.9        
Cash acquired from acquisition       1,200.0                    
Revenue reported by acquired entity for last annual period                     $ 2,800.0      
Goodwill       9,600.0           9,556.2        
Payments to acquire businesses, gross       2,500.0                    
Net cash consideration                   13,577.6        
Transaction costs                   47.0        
Nobel Biocare                            
Business Acquisition [Line Items]                            
Assumed debt             132.7   132.7     132.7    
Revenue reported by acquired entity for last annual period                         780.0 € 567
Goodwill                 1,000.0     1,013.6    
Net cash consideration             1,900.0 SFr 1,900            
Transaction costs             12.0   12.0     12.0    
Others                            
Business Acquisition [Line Items]                            
Assumed debt             $ 5.8   $ 5.8 0.1   5.8    
Revenue reported by acquired entity for last annual period                   375.0   420.0 300.0  
Goodwill                   $ 306.0   $ 630.0 $ 518.0  
Number of businesses acquired | Business                   11   16 12 12
Net cash consideration                   $ 727.4   $ 1,300.0 $ 883.0  
Commercial paper | Pall Corporation                            
Business Acquisition [Line Items]                            
Net proceeds from debt       $ 8,100.0                    
Euro-denominated senior unsecured notes | Senior notes | Pall Corporation                            
Business Acquisition [Line Items]                            
Net proceeds from debt         $ 3,000.0 € 2,700                
U.S. dollar-denominated senior unsecured notes | Senior notes | Pall Corporation                            
Business Acquisition [Line Items]                            
Net proceeds from debt     $ 2,000.0                      
Swiss franc-denominated senior unsecured bonds | Bonds | Pall Corporation                            
Business Acquisition [Line Items]                            
Net proceeds from debt SFr 755 $ 732.0                        
Fair value adjustment to inventory | Pall Corporation                            
Business Acquisition [Line Items]                            
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest                   91.0        
Fair value adjustment to inventory | Nobel Biocare                            
Business Acquisition [Line Items]                            
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest                   $ 20.0   $ 5.0